Issue navigation
Volume 104, Issue 3, 8 February 2012
Study Showed Oxaliplatin Improved Colon Cancer Patient Survival
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Page 1, https://doi.org/10.1093/jnci/djs028
IN THIS ISSUE
IN THIS ISSUE
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Page 165, https://doi.org/10.1093/jnci/djs023
MEMO TO THE MEDIA
Self-Collection and HPV DNA Testing Could Be an Effective Cervical Cancer Screening Method
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Page NP, https://doi.org/10.1093/jnci/djs029
Younger Breast Cancer Patients Have More Adverse Quality of Life Issues
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Page NP, https://doi.org/10.1093/jnci/djs030
EDITORIAL
Is It Time to Introduce HPV Self-Sampling for Primary Cervical Cancer Screening?
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Pages 166–167, https://doi.org/10.1093/jnci/djr544
NEWS
The “Gray Market” Raises Concerns about Cost, Safety, and Ethics
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Pages 168–170, https://doi.org/10.1093/jnci/djs024
StatBite Pharmaceutical Drugs
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Page 169, https://doi.org/10.1093/jnci/djs026
CDC Launches Infection Awareness Initiative for Cancer Patients
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Pages 170–172, https://doi.org/10.1093/jnci/djs020
New Data on Aspirin and Colorectal Cancer Brings Calls for New Guidelines, More Research
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Pages 172–177, https://doi.org/10.1093/jnci/djs019
Genetic Discoveries Propagate New Epigenetic Drugs
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Pages 174–176, https://doi.org/10.1093/jnci/djs021
Physician Data Query (PDQ®) Update
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Page 176, https://doi.org/10.1093/jnci/djs025
Erratum
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Page 177, https://doi.org/10.1093/jnci/djs022
ARTICLES
Pooled Analysis of a Self-Sampling HPV DNA Test as a Cervical Cancer Primary Screening Method
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Pages 178–188, https://doi.org/10.1093/jnci/djr532
Immunotherapeutic Potential of Anti-Human Endogenous Retrovirus-K Envelope Protein Antibodies in Targeting Breast Tumors
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Pages 189–210, https://doi.org/10.1093/jnci/djr540
Comparative Effectiveness of Oxaliplatin vs Non–Oxaliplatin-containing Adjuvant Chemotherapy for Stage III Colon Cancer
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Pages 211–227, https://doi.org/10.1093/jnci/djr524
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Pages 228–239, https://doi.org/10.1093/jnci/djr523
Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein–Barr Virus Status–Defined Subgroups
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Pages 240–253, https://doi.org/10.1093/jnci/djr516
CORRESPONDENCE
Re: Inconsistencies in Findings From the Early Lung Cancer Action Project Studies of Lung Cancer Screening
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Page 254, https://doi.org/10.1093/jnci/djr520
Re: Inconsistencies in Findings from the Early Lung Cancer Action Project Studies of Lung Cancer Screening
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Pages 254–255, https://doi.org/10.1093/jnci/djr521
Response: Re: Inconsistencies in Findings from the Early Lung Cancer Action Project Studies of Lung Cancer Screening
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Pages 255–256, https://doi.org/10.1093/jnci/djr522
COVER
Cover
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Page NP, https://doi.org/10.1093/jnci/djs097
STANDING MATERIALS
TABLE OF CONTENTS
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Page NP, https://doi.org/10.1093/jnci/djs100
EDITORIAL BOARD
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Page NP, https://doi.org/10.1093/jnci/djs098
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Page NP, https://doi.org/10.1093/jnci/djs099
